- 15th Annual BIO CEO &
Investor Conference on February 12th
-
- Leerink Swann Global Healthcare Conference 2013 on February 13th
-
- Webcasts Available Through Gilead Corporate Website -
FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 11, 2013--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company
will be webcasting its corporate presentation at two upcoming investor
conferences: the BIO CEO & Investor Conference and the Leerink Swann
Global Healthcare Conference 2013, both taking place in New York.
John F. Milligan, PhD, Gilead’s President and Chief Operating Officer,
will provide an overview of the company at the BIO conference on
Tuesday, February 12 at 11:00 a.m. Eastern Time (ET) and the Leerink
Swann conference on Wednesday, February 13 at 10:30 a.m. ET.
To access the live webcasts or replays via the internet log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be necessary to listen to the webcast. The replay will
be available for 14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Asia
Pacific.
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
(1-800-445-3235).
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.Patrick O’Brien, 650-522-1936Investor
Relations
